MDC — Mediclinic International Balance Sheet
0.000.00%
HealthcareBalancedLarge Cap
- £3.69bn
- £6.12bn
- £3.23bn
Annual balance sheet for Mediclinic International, fiscal year end - March 31st, GBP millions except per share, conversion factor applied.
2018 March 31st | 2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 262 | 266 | 331 | 296 | 540 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 608 | 733 | 730 | 780 | 778 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 961 | 1,091 | 1,213 | 1,232 | 1,474 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 3,590 | 3,524 | 4,358 | 4,052 | 4,385 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 6,343 | 6,428 | 6,954 | 6,672 | 7,207 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 525 | 586 | 769 | 684 | 823 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 3,057 | 3,277 | 4,064 | 3,823 | 4,100 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Other Equity | |||||
| Total Equity | 3,286 | 3,151 | 2,890 | 2,849 | 3,107 |
| Total Liabilities & Shareholders' Equity | 6,343 | 6,428 | 6,954 | 6,672 | 7,207 |
| Total Common Shares Outstanding |